Author details

Full Name

Elisabeth Brouwer

Affiliation

ORCID

Career Start Year

1984

Papers

235

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37507207	External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic.		2023
35961758	Expression of interleukin-6 in synovial tissue of patients with polymyalgia rheumatica.	Ann Rheum Dis	2023
37848964	High BMI is associated with lower TNF-Î± inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis.		2023
37600779	Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.		2023
37650990	Diagnostic delay in patients with giant cell arteritis: results of a fast-track clinic.		2023
37639896	Early referral of patients with suspected polymyalgia rheumatica - A systematic review.		2023
38079331	Salivary gland 18F-FDG-PET/CT uptake patterns in SjÃ¶gren's syndrome and giant cell arteritis patients.		2023
37791984	Increased diagnostic accuracy of the labial gland biopsy in primary SjÃ¶gren's syndrome when multiple histopathological features are included.		2023
37632778	Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls.		2023
37703805	Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.		2023
36969157	Mucosal-associated invariant T cells in patients with axial spondyloarthritis.		2023
37398666	Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients.		2023
37332051	Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster.		2023
36637182	An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.	Rheumatology (Oxford)	2023
37011940	Role of F-FDG PET/CT in Large Vessel Vasculitis and Polymyalgia Rheumatica.		2023
37003681	Positron Emission Tomography Imaging in Vasculitis.		2023
36631159	Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.		2023
37443554	Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud's Phenomenon in the Lifelines Population: Focus on Pulmonary Complications.		2023
37382453	Higher skin autofluorescence in individuals at risk for rheumatoid arthritis: results from a large population-based cohort.		2023
36746990	Monocyte subsets and monocyte-related chemokines in Takayasu arteritis.		2023
37438402	Effect of DMARDs on the immunogenicity of vaccines.		2023
37057491	Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis.		2023
37238153	Ultrasound for the Detection of Inflammatory Abdominal Aortic Aneurysms: A Case and Validation Series.		2023
36468520	Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits.	Arthritis and Rheumatology	2023
37164013	Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire.	Immunity	2023
35166769	Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply.	Rheumatology	2022
35460236	Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8+ T cells in giant cell arteritis.	Rheumatology	2022
36359537	A Case of Clinical Uncertainty Solved: Giant Cell Arteritis with Polymyalgia Rheumatica Swiftly Diagnosed with Long Axial Field of View PET.	Diagnostics	2022
36032100	Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica.	Front Immunol	2022
35733858	Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.	Frontiers in Medicine	2022
35537222	Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.	Seminars in Arthritis and Rheumatism	2022
37920851	Transcriptomic-based clustering of human atherosclerotic plaques identifies subgroups with different underlying biology and clinical presentation.	Nat Cardiovasc Res	2022
32241799	Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.	Annals of the Rheumatic Diseases	2022
34117743	Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica.	Rheumatology	2022
32887684	Management of immune checkpoint inhibitor-induced polymyalgia rheumatica.	Annals of the Rheumatic Diseases	2022
35255968	Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.		2022
34730794	Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.	Rheumatology	2022
34508583	Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis.	Rheumatology	2022
35264321	Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.	Ann Rheum Dis	2022
34718434	New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.	Rheumatology (Oxford)	2022
35151886	Letter to the editor: Prevalence of connective tissue disease autoantibodies in a large longitudinal population-based cohort from the Netherlands.	Autoimmunity Reviews	2022
35149602	Need and value of targeted immunosuppressive therapy in giant cell arteritis.	RMD Open	2022
34530137	Distribution of monocytes subpopulations in the peripheral blood from patients with BehÃ§et's disease - Impact of disease status and colchicine use.	Clinical Immunology	2021
34237649	Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.	Journal of Autoimmunity	2021
33909889	Therapy response evaluation in large-vessel vasculitis: a new role for [18F]FDG-PET/CT?	Rheumatology	2021
33806941	A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis.	Journal of Personalized Medicine	2021
33806304	Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis Patients.	International Journal of Environmental Research and Public Health	2021
34168654	CD27CD38CD21 B-Cells Are Increased in Axial Spondyloarthritis.	Frontiers in Immunology	2021
33521671	Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective.	Lancet Rheumatology, The	2021
34105308	A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor Î±2 Axis.	Arthritis and Rheumatology	2021